Limitations of Paraneoplastic Panel in Neurological Disease Screening

The chapter emphasizes focusing on high-risk patients for cancer-associated neurological diseases rather than general screening using a paraneoplastic panel. It discusses novel antibody discovery through indirect immunofluorescence and the challenges in identifying unclassified antibodies in autoimmune encephalitis, highlighting techniques like protein arrays and phage display immunoprecipitation sequencing.